Increased plasma proteasome chymotrypsin-like activity in patients with advanced solid tumors

Diagnostic value and prognostic significance of plasmatic proteasome level in patients with melanoma

(2010) Laurent Henry et al.   EXPERIMENTAL DERMATOLOGY

The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer

(2010) Martin Heubner et al.   GYNECOLOGIC ONCOLOGY

Ubiquitin–proteasome system profiling in acute leukemias and its clinical relevance

(2010) Wanlong Ma et al.   LEUKEMIA RESEARCH

Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome

(2009) W. Ma et al.   CLINICAL CANCER RESEARCH

Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis

(2009) L Henry et al.   GUT

Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer

(2008) Ryo Takagawa et al.   ANNALS OF SURGICAL ONCOLOGY

Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia

(2008) Wanlong Ma et al.   CANCER

Assessment of circulating proteasome chymotrypsin-like activity in plasma of patients with acute and chronic leukemias

(2008) Halina Ostrowska et al.   CLINICAL BIOCHEMISTRY

Proteasome inhibitors: a therapeutic strategy for haematological malignancy

(2008) Lisa Judith-Ann Crawford   Frontiers in Bioscience-Landmark